- Current report filing (8-K)
March 22 2010 - 4:21PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
March 19,
2010
THE
MACERICH COMPANY
(Exact Name of
Registrant as Specified in Charter)
Maryland
|
|
1-12504
|
|
95-4448705
|
(State or Other
|
|
(Commission
|
|
(I.R.S. Employer
|
Jurisdiction of
|
|
File Number)
|
|
Identification
No.)
|
Incorporation)
|
|
|
|
|
|
|
|
|
|
401
Wilshire Boulevard, Suite 700
Santa Monica, California
|
|
90401
|
(Address of
Principal Executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
(310) 394-6000
Former name or
former address, if changed since last report:
N/A
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see
General Instructions A.2.):
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Item
8.01. Other Events.
On February 18, 2010,
The Macerich Company (the Company) filed with the U.S. Securities and
Exchange Commission (the SEC) a prospectus supplement dated February 18,
2010 (the February Prospectus Supplement) to its prospectus dated November 26,
2008, which was included in its automatic shelf registration statement on Form S-3
(No. 333-155742) (the Registration Statement). The February Prospectus
Supplement relates to the 430,085 shares of the Companys common stock that
were or may be issued in connection with a distribution made by The Macerich
Partnership, L.P., the Companys operating partnership, on March 22, 2010.
The Company is filing the
opinion of its counsel, Venable LLP, as Exhibit 5.1 hereto, regarding the
legality of the shares of common stock covered by the February Prospectus
Supplement.
Additionally, on March 19,
2010, the Company filed with the SEC a prospectus supplement dated March 19,
2010 (the March Prospectus Supplement) to its prospectus dated November 26,
2008, which was included in the Registration Statement. The March Prospectus Supplement relates
to the 50,000 shares of the Companys common stock that may be issued in
connection with adjustments to the conversion ratios of certain outstanding
units that may be redeemed for the Companys common stock.
The Company is filing the
opinion of its counsel, Venable LLP, as Exhibit 5.2 hereto, regarding the
legality of the shares of common stock covered by the March Prospectus
Supplement.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits
The following exhibits
are filed with this report:
Exhibit
Number
|
|
Description of Exhibits
|
|
|
|
+5.1
|
|
Opinion of Venable LLP
as to the legality of the securities being registered.
|
|
|
|
+5.2
|
|
Opinion of Venable LLP
as to the legality of the securities being registered.
|
|
|
|
+23.1
|
|
Consent of Venable LLP
(contained in its opinion filed as Exhibit 5.1 and incorporated herein
by reference).
|
|
|
|
+23.2
|
|
Consent of Venable LLP
(contained in its opinion filed as Exhibit 5.2 and incorporated herein
by reference).
|
2
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
|
THE MACERICH COMPANY
|
|
By: Richard A. Bayer
|
|
|
|
|
|
/s/ Richard A. Bayer
|
|
Senior Executive Vice
President,
Chief Legal
Officer and Secretary
|
Date: March 22, 2010
3
EXHIBIT
INDEX
Exhibit
Number
|
|
Description of Exhibits
|
|
|
|
+5.1
|
|
Opinion of Venable LLP
as to the legality of the securities being registered.
|
|
|
|
+5.2
|
|
Opinion of Venable LLP
as to the legality of the securities being registered.
|
|
|
|
+23.1
|
|
Consent of Venable LLP
(contained in its opinion filed as Exhibit 5.1 and incorporated herein
by reference).
|
|
|
|
+23.2
|
|
Consent of Venable LLP
(contained in its opinion filed as Exhibit 5.2 and incorporated herein
by reference).
|
4
Macerich (NYSE:MAC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Macerich (NYSE:MAC)
Historical Stock Chart
From Jul 2023 to Jul 2024